Boehringer Ingelheim has opened another front in its attack on chronic kidney disease (CKD), offering Rectify Pharmaceuticals up to $448 million to partner on a preclinical program. The alliance ...

The end of each year presents opportunities to share program specials that encourage us to look back on the past year, look ahead to the new year, or just pause and linger in the current moment. As we ...

This holiday season, reflect on the key moments of 2025 and enjoy the sounds of the season with holiday music from a wide range of styles and stories with humor, warmth and festivity. Here are some ...